Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-12-08

Clinical Trial Update: Decitabine and HQP1351-based Chemotherapy Regimen for the Treatment Advanced CML [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a decitabine and HQP1351-based chemotherapy regimen for advanced chronic myeloid leukemia with blast crisis/transformations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Decitabine (Decitabine)
  • HQP1351

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Chronic Myeloid Leukemia in Myeloid Blast Crisis, Chronic Myeloid Leukaemia Transformation | Phase 2 | Status: UNKNOWN